日本語View as Markdown

Protective Effects of Hydrogen against Low-Dose Long-Term Radiation-Induced Damage to the Behavioral Performances, Hematopoietic System, Genital System, and Splenic Lymphocytes in Mice.

低線量長期放射線照射によるマウスの行動・造血・生殖・脾臓リンパ球への障害に対する水素の防護効果

animal study animal model positive

Abstract

This mouse study examined whether molecular hydrogen (H₂) could mitigate multi-system damage arising from low-dose long-term gamma radiation (LDLTR). Animals received whole-body irradiation at doses of 0.1, 0.5, 1.0, or 2.0 Gy, and a comprehensive battery of assessments was conducted after the final exposure: body mass monitoring, forced swim test, open field test, chromosome aberration analysis, peripheral blood cell counts, sperm abnormality evaluation, lymphocyte transformation test, and histopathological examination. Across all dose levels, H₂-treated mice showed statistically significant improvements compared with radiation-only controls in behavioral performance, hematopoietic indices, reproductive parameters, and splenic lymphocyte function, indicating that H₂ exerts broad protective effects against LDLTR-induced injury in multiple biological systems.

Mechanism

H₂ is proposed to reduce radiation-induced oxidative stress and chromosomal aberrations, thereby attenuating functional impairment across hematopoietic, reproductive, and immune compartments following chronic low-dose gamma irradiation.

Bibliographic

Authors
Guo J, Zhao D, Lei X, Zhao H, Yang Y, Zhang P, et al.
Journal
Oxid Med Cell Longev
Year
2016
PMID
27774116
DOI
10.1155/2016/1947819
PMC
PMC5059652

Tags

Disease:がん放射線療法 (副作用軽減) Mechanism:抗酸化酵素 ヒドロキシルラジカル消去 免疫調節 炎症抑制 酸化ストレス 活性酸素種

Delivery context

This study is at the animal-experiment stage. For human application, inhalation is the most promising delivery route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration devices are documented in the Consumer Affairs Agency accident database and are not recommended).

Safety notes

This study is at the animal-experiment stage. For human application, inhalation is the most promising delivery route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration devices are documented in the Consumer Affairs Agency accident database and are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 27774116. https://h2-papers.org/en/papers/27774116
Source: PubMed PMID 27774116